Analysis of XiaoHongShu's Organizational Restructuring and Its Impact on R&D Management
The article examines XiaoHongShu's recent organizational overhaul—cancelling the professional R‑sequence, removing the L0 team‑lead role, and shifting to direct appointment by senior management—while discussing the underlying issues of “big‑company disease,” the concept of an upward career channel, and proposing systematic solutions to restore effective talent evaluation and resource allocation.